Medicus Sciences Acquisition (Medicus Sciences Acquisition) EBITDA Margin % : 0.00% (As of Sep. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Medicus Sciences Acquisition EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Medicus Sciences Acquisition's EBITDA for the three months ended in Sep. 2022 was $-0.17 Mil. Medicus Sciences Acquisition's Revenue for the three months ended in Sep. 2022 was $0.00 Mil. Therefore, Medicus Sciences Acquisition's EBITDA margin for the quarter that ended in Sep. 2022 was 0.00%.

Medicus Sciences Acquisition EBITDA Margin % Historical Data

The historical data trend for Medicus Sciences Acquisition's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicus Sciences Acquisition EBITDA Margin % Chart

Medicus Sciences Acquisition Annual Data

Trend

Dec20

Dec21

EBITDA Margin %

Medicus Sciences Acquisition Quarterly Data
	Nov20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
EBITDA Margin %	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Medicus Sciences Acquisition's EBITDA Margin %

For the Shell Companies subindustry, Medicus Sciences Acquisition's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medicus Sciences Acquisition's EBITDA Margin % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Medicus Sciences Acquisition's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Medicus Sciences Acquisition's EBITDA Margin % falls into.

Medicus Sciences Acquisition EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Medicus Sciences Acquisition's EBITDA Margin % for the fiscal year that ended in Dec. 2021 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2021 )	/	Revenue (A: Dec. 2021 )
	=	-0.615	/	0
	=	%

Medicus Sciences Acquisition's EBITDA Margin % for the quarter that ended in Sep. 2022 is calculated as

EBITDA Margin %	=	EBITDA (Q: Sep. 2022 )	/	Revenue (Q: Sep. 2022 )
	=	-0.174	/	0
	=	%

Medicus Sciences Acquisition (NAS:MSAC) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Medicus Sciences Acquisition EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Medicus Sciences Acquisition's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicus Sciences Acquisition (Medicus Sciences Acquisition) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Medicus Sciences Acquisition Corp (NAS:MSAC) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

152 West 57th Street, Floor 20, New York, NY, USA, 10019

Website

https://www.medicusspac.com

Medicus Sciences Acquisition Corp is a blank check company.

Executives

Eric Cheng	officer: Chief Business Officer	152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Kenneth Berkovitz	director	152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Christopher Kaster	director	152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Ross Levine	director	152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Judah Drillick	officer: Chief Financial Officer	152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Jacob Gottlieb	director, 10 percent owner, officer: Executive Chairman	152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Medicus Sciences Holdings Llc	10 percent owner	152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Michael Castor	director, 10 percent owner, officer: Chief Executive Officer	152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019

Medicus Sciences Acquisition (Medicus Sciences Acquisition) Headlines

From GuruFocus

Medicus Sciences Acquisition Corp. Announces Closing of $92,000,000 Initial Public Offering and Full Exercise of the Overallotment Option

By PRNewswire PRNewswire • 02-18-2021

Medicus Sciences Acquisition Corp. Announces Pricing of $80,000,000 Initial Public Offering

By PRNewswire PRNewswire • 02-16-2021

Medicus Sciences Acquisition Corp. Announces Liquidation

By PRNewswire PRNewswire • 02-13-2023